| |
| |
|
| Insider
Information: |
Duvall Martin J |
| Relationship: |
Chief Executive Office... |
| City: |
Bloomington |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
113,144 |
|
|
Indirect Shares
|
585 |
|
|
| Direct
Value |
$17,142 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
113,729 |
|
|
| Total
Value |
$17,142 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
MGI Pharma Inc |
MOGN |
Sr VP Commercial Opera... |
2005-12-16 |
6,500 |
2005-12-16 |
585 |
Premium* |
|
|
Ariad Pharmaceuticals Inc |
ARIA |
EVP, CCO |
2016-03-19 |
93,039 |
2013-03-20 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
Chief Executive Office... |
2019-05-28 |
13,605 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MOGN |
MGI Pharma Inc |
Sr VP Commercial OperationsOff |
• – – |
2005-01-18 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
76 |
|
- |
|
| MOGN |
MGI Pharma Inc |
officerTitle |
• – – |
2005-12-16 |
4 |
B |
$16.50 |
$4,951 |
D/D |
300 |
6,800 |
2.66 |
- |
|
| MOGN |
MGI Pharma Inc |
officerTitle |
• – – |
2005-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
6,500 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-03-20 |
4 |
D |
$8.13 |
$4,301 |
D/D |
(529) |
30,340 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Commercial Operations |
• • – |
2013-03-22 |
4 |
S |
$19.53 |
$11,249 |
D/D |
(576) |
2,854 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-03-23 |
4 |
AS |
$8.57 |
$7,145 |
D/D |
(834) |
54,950 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$5,085 |
D/D |
(913) |
35,450 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$11,956 |
D/D |
(1,400) |
59,748 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,666 |
30,869 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Commercial Operations |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
3,430 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
55,784 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Executive Officer |
• • – |
2017-12-08 |
4 |
A |
$8.50 |
$21,250 |
D/D |
2,500 |
6,071 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$21,441 |
D/D |
(2,618) |
29,203 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
36,363 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
61,148 |
0 |
- |
|
| MOGN |
MGI Pharma Inc |
Sr VP Commercial Operations |
• – – |
2005-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,500 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr VP Commercial Operations |
• – – |
2005-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
3,500 |
|
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Executive Officer |
• • – |
2017-04-19 |
4 |
A |
$10.00 |
$35,710 |
D/D |
3,571 |
3,571 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-03-20 |
4 |
AS |
$8.85 |
$35,381 |
D/D |
(4,000) |
54,117 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• – – |
2016-03-19 |
4 |
AS |
$6.47 |
$25,867 |
D/D |
(4,000) |
93,039 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-09-28 |
4 |
AS |
$6.46 |
$32,317 |
D/D |
(5,000) |
64,748 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Executive Officer |
• • – |
2019-05-28 |
4 |
B |
$4.34 |
$21,679 |
D/D |
5,000 |
13,605 |
2.81 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Commercial Operations |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,600 |
9,739 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
31,821 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
58,117 |
0 |
- |
|
35 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
